EML1

gene
On this page

Also known as EMAPHuEMAPELP79

Summary

EML1 (EMAP like 1, HGNC:3330) is a protein-coding gene on chromosome 14q32.2, encoding Echinoderm microtubule-associated protein-like 1 (O00423). Modulates the assembly and organization of the microtubule cytoskeleton, and probably plays a role in regulating the orientation of the mitotic spindle and the orientation of the plane of cell division.

Human echinoderm microtubule-associated protein-like is a strong candidate for the Usher syndrome type 1A gene. Usher syndromes (USHs) are a group of genetic disorders consisting of congenital deafness, retinitis pigmentosa, and vestibular dysfunction of variable onset and severity depending on the genetic type. The disease process in USHs involves the entire brain and is not limited to the posterior fossa or auditory and visual systems. The USHs are catagorized as type I (USH1A, USH1B, USH1C, USH1D, USH1E and USH1F), type II (USH2A and USH2B) and type III (USH3). The type I is the most severe form. Gene loci responsible for these three types are all mapped. Two transcript variants encoding different isoforms have been found for this gene.

Source: NCBI Gene 2009 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): band heterotopia of brain (Definitive, ClinGen) — +1 more curated relationship
  • GWAS associations: 9
  • Clinical variants (ClinVar): 254 total — 8 pathogenic, 3 likely-pathogenic
  • Phenotypes (HPO): 19
  • MANE Select transcript: NM_004434

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:3330
Approved symbolEML1
NameEMAP like 1
Location14q32.2
Locus typegene with protein product
StatusApproved
AliasesEMAP, HuEMAP, ELP79
Ensembl geneENSG00000066629
Ensembl biotypeprotein_coding
OMIM602033
Entrez2009

Gene structure

Transcript identifiers

Ensembl transcripts: 30 — 22 protein_coding, 3 retained_intron, 3 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined

ENST00000262233, ENST00000327921, ENST00000334192, ENST00000553313, ENST00000553720, ENST00000554111, ENST00000554386, ENST00000554479, ENST00000554553, ENST00000555096, ENST00000555145, ENST00000555277, ENST00000555812, ENST00000556199, ENST00000556714, ENST00000556758, ENST00000556835, ENST00000556947, ENST00000557313, ENST00000557741, ENST00000649352, ENST00000697131, ENST00000909078, ENST00000909079, ENST00000909080, ENST00000909081, ENST00000909082, ENST00000912116, ENST00000940979, ENST00000940980

RefSeq mRNA: 4 — MANE Select: NM_004434 NM_001008707, NM_001375411, NM_001375412, NM_004434

CCDS: CCDS32154, CCDS32155

Canonical transcript exons

ENST00000262233 — 22 exons

ExonStartEnd
ENSE000009414759989462999894758
ENSE000009414839991456699914697
ENSE000009414849991778299917849
ENSE000009964889989119999891227
ENSE000013635839993998799942060
ENSE000034776789985085399851035
ENSE000034950089989714599897294
ENSE000035169929989823399898302
ENSE000035274459992078999920877
ENSE000035425219986551499865646
ENSE000035526509993919799939327
ENSE000035674709987848599878619
ENSE000035864129993602999936126
ENSE000036215469991024299910341
ENSE000036217589993781799937912
ENSE000036384349993624799936334
ENSE000036387649990763899907733
ENSE000036391189991417999914304
ENSE000036734859991142299911576
ENSE000036850729990934599909479
ENSE000036868359990092999901039
ENSE000039000219979341399793543

Expression profiles

Bgee: expression breadth ubiquitous, 285 present calls, max score 98.51.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.8567 / max 217.5538, expressed in 1410 samples.

FANTOM5 promoters (7 alternative TSS)

Promoter IDTPM avgSamples expressed
1414045.89631306
1414032.36461063
1413981.3523466
1414020.7214445
1414010.2644115
1414000.179852
1413990.078043

Top tissues by expression

296 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cortical plateUBERON:000534398.51gold quality
ganglionic eminenceUBERON:000402395.60gold quality
mucosa of stomachUBERON:000119994.67gold quality
synovial jointUBERON:000221794.29gold quality
colonic epitheliumUBERON:000039793.00gold quality
ventricular zoneUBERON:000305392.53gold quality
esophagogastric junction muscularis propriaUBERON:003584192.25gold quality
muscle layer of sigmoid colonUBERON:003580591.77gold quality
calcaneal tendonUBERON:000370191.75gold quality
lower esophagus muscularis layerUBERON:003583391.50gold quality
lower esophagusUBERON:001347391.45gold quality
endometrium epitheliumUBERON:000481190.76gold quality
tendonUBERON:000004390.50gold quality
right lungUBERON:000216790.46gold quality
amniotic fluidUBERON:000017390.38gold quality
stromal cell of endometriumCL:000225590.26gold quality
tendon of biceps brachiiUBERON:000818890.08gold quality
sural nerveUBERON:001548889.59gold quality
gall bladderUBERON:000211089.05gold quality
middle frontal gyrusUBERON:000270288.45gold quality
frontal poleUBERON:000279588.43gold quality
bronchial epithelial cellCL:000232888.10gold quality
hindlimb stylopod muscleUBERON:000425287.84gold quality
corpus callosumUBERON:000233687.67gold quality
descending thoracic aortaUBERON:000234587.20gold quality
right coronary arteryUBERON:000162586.77gold quality
caudate nucleusUBERON:000187386.68gold quality
pigmented layer of retinaUBERON:000178286.59gold quality
retinaUBERON:000096686.58gold quality
apex of heartUBERON:000209886.52gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-CURD-119yes29.20
E-ANND-3yes10.10

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

115 targeting EML1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-30A-5P100.0076.313233
HSA-MIR-30B-5P100.0076.293248
HSA-MIR-30C-5P100.0076.293248
HSA-MIR-30D-5P100.0076.323233
HSA-MIR-30E-5P100.0076.323242
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-340-5P100.0072.504437
HSA-MIR-4455100.0065.481587
HSA-MIR-6873-3P100.0071.422626
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-998599.9872.112939
HSA-MIR-19A-3P99.9875.332762
HSA-MIR-19B-3P99.9875.442754
HSA-MIR-548AN99.9770.912817
HSA-MIR-4666A-3P99.9671.713434
HSA-MIR-590-3P99.9674.346478
HSA-MIR-128-3P99.9571.172484
HSA-MIR-216A-3P99.9571.192505
HSA-MIR-3912-5P99.9566.11925
HSA-MIR-391099.9571.132227
HSA-LET-7C-3P99.9573.422862
HSA-MIR-101-3P99.9475.032230

Literature-anchored findings (GeneRIF, showing 8)

  • determined a 2.6-A crystal structure of the representative approximately 70-kDa core of EML1, revealing an intimately associated pair of beta-propellers, which we term a TAPE (tandem atypical propeller in EMLs) domain (PMID:24706829)
  • We found EML1 to be mutated in ribbon-like heterotopia in humans (PMID:24859200)
  • We show that the trimerization domain (TD) of EML1 is necessary and sufficient for self-association. The TD is also essential for MT binding; however, this property requires an adjacent basic region. (PMID:25740311)
  • a homozygous truncating variant in EML1 is a novel cause of congenital hydrocephalus. (PMID:28556411)
  • Mutations in the Heterotopia Gene Eml1/EML1 Severely Disrupt the Formation of Primary Cilia. (PMID:31390572)
  • biallelic EML1 disease-causing variants cause a highly specific pattern of congenital brain malformations, severe developmental delay, seizures and visual impairment (PMID:31710781)
  • A novel missense variant in the EML1 gene associated with bilateral ribbon-like subcortical heterotopia leads to ciliary defects. (PMID:34211111)
  • Human cerebral organoids reveal progenitor pathology in EML1-linked cortical malformation. (PMID:35289477)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_rerioeml1ENSDARG00000042840
mus_musculusEml1ENSMUSG00000058070
rattus_norvegicusEml1ENSRNOG00000043143

Paralogs (9): EML2 (ENSG00000125746), EML4 (ENSG00000143924), EML3 (ENSG00000149499), CFAP251 (ENSG00000158023), WDR90 (ENSG00000161996), EML5 (ENSG00000165521), CFAP52 (ENSG00000166596), CFAP44 (ENSG00000206530), EML6 (ENSG00000214595)

Protein

Protein identifiers

Echinoderm microtubule-associated protein-like 1O00423 (reviewed: O00423)

All UniProt accessions (16): O00423, A0A3B3IU69, A0A8V8TKR4, F8W717, G3V3J1, G3V3N9, G3V497, G3V4H6, G3V4U5, G3V500, G3V538, G3V5C8, H0YJD8, H0YJK4, H0YJS9, H0YJY3

UniProt curated annotations — full annotation on UniProt →

Function. Modulates the assembly and organization of the microtubule cytoskeleton, and probably plays a role in regulating the orientation of the mitotic spindle and the orientation of the plane of cell division. Required for normal proliferation of neuronal progenitor cells in the developing brain and for normal brain development. Does not affect neuron migration per se.

Subunit / interactions. Homotrimer; self-association is mediated by the N-terminal coiled coil. Does not interact with EML3. Binds repolymerizing microtubules. Binds unpolymerized tubulins via its WD repeat region. Interacts with TASOR.

Subcellular location. Cytoplasm. Perinuclear region. Cytoskeleton.

Tissue specificity. Ubiquitous; expressed in most tissues with the exception of thymus and peripheral blood lymphocytes.

Disease relevance. Band heterotopia (BH) [MIM:600348] A brain malformation of the lissencephaly spectrum, resulting from disordered neuronal migration and characterized by bands of gray matter interposed in the central white matter. Disease features include severe developmental delay with intellectual disability, enlarged head circumference, periventricular and ribbon-like subcortical heterotopia, polymicrogyria and agenesis of the corpus callosum. The disease is caused by variants affecting the gene represented in this entry.

Domain organisation. Contains a tandem atypical propeller in EMLs (TAPE) domain. The N-terminal beta-propeller is formed by canonical WD repeats; in contrast, the second beta-propeller contains one blade that is formed by discontinuous parts of the polypeptide chain. The N-terminal coiled coil is required for association with microtubules.

Similarity. Belongs to the WD repeat EMAP family.

Isoforms (2)

UniProt IDNamesCanonical?
O00423-11yes
O00423-33

RefSeq proteins (4): NP_001008707, NP_001362340, NP_001362341, NP_004425* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001680WD40_rptRepeat
IPR005108HELPConserved_site
IPR011047Quinoprotein_ADH-like_sfHomologous_superfamily
IPR015943WD40/YVTN_repeat-like_dom_sfHomologous_superfamily
IPR036322WD40_repeat_dom_sfHomologous_superfamily
IPR050630WD_repeat_EMAPFamily
IPR055439Beta-prop_EML_1stDomain
IPR055442Beta-prop_EML-like_2ndDomain

Pfam: PF03451, PF23409, PF23414

UniProt features (115 total): strand 58, repeat 12, turn 10, mutagenesis site 8, sequence conflict 7, sequence variant 6, helix 4, compositionally biased region 4, region of interest 2, chain 1, coiled-coil region 1, modified residue 1, splice variant 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
4CI8X-RAY DIFFRACTION2.6

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O00423-F186.490.76

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 113

Mutagenesis-validated functional residues (8):

PositionPhenotype
59–61no effect on tubulin binding. does not disrupt self-association. decreased association with microtubules.
192abolishes tubulin binding; when associated with s-194; a-547; t-626; s-627; a-646 and a-786.
194abolishes tubulin binding; when associated with s-192; a-547; t-626; s-627; a-646 and a-786.
547abolishes tubulin binding; when associated with s-192; s-194; t-626; s-627; a-646 and a-786.
626abolishes tubulin binding; when associated with s-192; s-194; a-547; s-627; a-646 and a-786.
627abolishes tubulin binding; when associated with s-192; s-194; a-547; t-626; a-646 and a-786.
646abolishes tubulin binding; when associated with s-192; s-194; a-547; t-626; s-627 and a-786.
786abolishes tubulin binding; when associated with s-192; s-194; a-547; t-626; s-627 and a-646.

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 190 (showing top): GOBP_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION, GOBP_NEUROGENESIS, FOXO1_01, GOBP_NEURAL_PRECURSOR_CELL_PROLIFERATION, PAX8_B, MYOD_01, DELYS_THYROID_CANCER_DN, MODULE_99, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5, ONDER_CDH1_TARGETS_2_UP, GOBP_MITOTIC_CELL_CYCLE, HTF_01, HIF1_Q3, GOBP_HEAD_DEVELOPMENT, RFX1_02

GO Biological Process (5): microtubule cytoskeleton organization (GO:0000226), hematopoietic progenitor cell differentiation (GO:0002244), mitotic spindle organization (GO:0007052), neuroblast proliferation (GO:0007405), brain development (GO:0007420)

GO Molecular Function (4): calcium ion binding (GO:0005509), microtubule binding (GO:0008017), tubulin binding (GO:0015631), protein binding (GO:0005515)

GO Cellular Component (10): cytosol (GO:0005829), microtubule (GO:0005874), microtubule associated complex (GO:0005875), perinuclear region of cytoplasm (GO:0048471), mitotic spindle pole (GO:0097431), mitotic spindle midzone (GO:1990023), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), microtubule cytoskeleton (GO:0015630), mitotic spindle (GO:0072686)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
cytoplasm2
microtubule cytoskeleton2
mitotic spindle2
cytoskeleton organization1
microtubule-based process1
hemopoiesis1
cell differentiation1
mitotic cell cycle1
spindle organization1
microtubule cytoskeleton organization involved in mitosis1
generation of neurons1
neural precursor cell proliferation1
central nervous system development1
animal organ development1
head development1
metal ion binding1
tubulin binding1
cytoskeletal protein binding1
binding1
polymeric cytoskeletal fiber1
protein-containing complex1
spindle pole1
spindle midzone1
intracellular anatomical structure1
intracellular membraneless organelle1
cytoskeleton1
spindle1

Protein interactions and networks

STRING

1873 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
EML1ALKQ9UM73739
EML1NUP214P35658545
EML1KIF2AO00139492
EML1EGFRP00533471
EML1TMEM91Q6ZNR0453
EML1OR52E2Q8NGJ4450
EML1ANKRD13BQ86YJ7450
EML1KIAA0513O60268449
EML1ERMARDQ5T6L9448
EML1RCSD1Q6JBY9447
EML1TMEM25Q86YD3440
EML1ETV6P41212404
EML1KIF13AQ9H1H9398
EML1KIF5AQ12840398
EML1ARFGEF2Q9Y6D5396

IntAct

34 interactions, top by confidence:

ABTypeScore
EML1ISG20L2psi-mi:“MI:0915”(physical association)0.620
EML1CASP6psi-mi:“MI:0915”(physical association)0.560
EML1LAMP2psi-mi:“MI:0915”(physical association)0.560
EML1STIP1psi-mi:“MI:0915”(physical association)0.560
NUDCEML1psi-mi:“MI:0915”(physical association)0.560
KXD1HIP1psi-mi:“MI:0914”(association)0.530
EML1FXR1psi-mi:“MI:0915”(physical association)0.510
EML1PTENpsi-mi:“MI:0915”(physical association)0.370
EML1UBE3Apsi-mi:“MI:0915”(physical association)0.370
EML1ECE1psi-mi:“MI:0915”(physical association)0.370
ECE1EML1psi-mi:“MI:0915”(physical association)0.370
DCUN1D1RGSL1psi-mi:“MI:0914”(association)0.350
TUBB3TUBB8Bpsi-mi:“MI:0914”(association)0.350
EML1TUBBpsi-mi:“MI:0914”(association)0.350
TUBB2BPOTEFpsi-mi:“MI:0914”(association)0.350
FBXO28EML1psi-mi:“MI:0914”(association)0.350
EML1EML2psi-mi:“MI:0914”(association)0.350
VCPSHTN1psi-mi:“MI:0914”(association)0.350

BioGRID (51): EML1 (Affinity Capture-MS), EML1 (Affinity Capture-MS), ISG20L2 (Two-hybrid), EML1 (Proximity Label-MS), EML1 (Affinity Capture-MS), EML1 (Affinity Capture-Western), TUBA1A (Reconstituted Complex), TUBB3 (Reconstituted Complex), FBXO28 (Affinity Capture-MS), TUBB2A (Affinity Capture-MS), EML4 (Affinity Capture-MS), TUBB2B (Affinity Capture-MS), EML1 (Affinity Capture-MS), TUBB (Affinity Capture-MS), EML1 (Proximity Label-MS)

ESM2 similar proteins: A0A396ISC0, O00423, O13286, O17468, O61585, O94423, P26309, P38328, P43254, P53197, P78972, P93471, Q04199, Q05BC3, Q09373, Q12834, Q16MY0, Q2TAF3, Q32SG6, Q3E906, Q4PSE4, Q4V7Y7, Q4V8C3, Q54MZ3, Q5H7C0, Q5ZIU8, Q62623, Q652L2, Q6DIP5, Q6NVM2, Q6S7B0, Q7K0L4, Q7ZUV2, Q7ZVL2, Q7ZX22, Q86Y33, Q8BG40, Q8CFJ9, Q8L3Z8, Q8LPL5

Diamond homologs: O00423, O95834, Q05BC3, Q05BV3, Q26613, Q2TAF3, Q32P44, Q3UMY5, Q4V8C3, Q5SQM0, Q6DIP5, Q6ED65, Q6P6T4, Q6ZMW3, Q7TNG5, Q8BQM8, Q8VC03, Q9HC35, Q9N9X3, Q9VUI3, Q9Y1C1, B3MC74, B4JW81, B4KTK4, B4LJT7, B4MY77, P29829, Q9NFZ1, B6K1G6, O48847, Q15542, Q8C092, O22212, O45487, O75083, O88342, O93277, Q2KJH4, Q5RKI0, Q86HX1

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 26 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Selective autophagy566.3×5e-07
Aggrephagy559.1×7e-07
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand655.3×1e-07
Recycling pathway of L1553.3×1e-06
COPI-independent Golgi-to-ER retrograde traffic549.4×1e-06
Kinesins542.5×1e-06
Autophagy642.4×3e-07
Golgi-to-ER retrograde transport531.6×4e-06

GO biological processes:

GO termPartnersFoldFDR
microtubule cytoskeleton organization630.3×1e-05
mitotic cell cycle527.9×1e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

254 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic8
Likely pathogenic3
Uncertain significance106
Likely benign74
Benign52

Top pathogenic / likely-pathogenic (11)

Variant IDHGVSClassification
1031421NM_004434.3(EML1):c.1820+1G>CPathogenic
2133786NM_004434.3(EML1):c.1715_1735delinsAGAC (p.Ala572fs)Pathogenic
254258NM_004434.3(EML1):c.412C>T (p.Arg138Ter)Pathogenic
254260NM_004434.3(EML1):c.673T>C (p.Trp225Arg)Pathogenic
2754922NM_004434.3(EML1):c.753_765del (p.Ser252fs)Pathogenic
4796662NM_004434.3(EML1):c.547+1G>TPathogenic
548146NM_004434.3(EML1):c.1567C>T (p.Arg523Ter)Pathogenic
813332GRCh37/hg19 14q32.2(chr14:100317190-101012999)Pathogenic
1028240NM_004434.3(EML1):c.1897C>T (p.Arg633Ter)Likely pathogenic
1710368NM_004434.3(EML1):c.136C>T (p.Gln46Ter)Likely pathogenic
254259NM_004434.3(EML1):c.727A>G (p.Thr243Ala)Likely pathogenic

SpliceAI

4275 predictions. Top by Δscore:

VariantEffectΔscore
14:99793505:GCCT:Gdonor_gain1.0000
14:99850845:T:TAacceptor_gain1.0000
14:99850850:TAG:Tacceptor_gain1.0000
14:99850851:A:AGacceptor_gain1.0000
14:99850851:AG:Aacceptor_loss1.0000
14:99850851:AGA:Aacceptor_gain1.0000
14:99850852:G:GTacceptor_gain1.0000
14:99850852:GAT:Gacceptor_gain1.0000
14:99851019:G:GTdonor_gain1.0000
14:99851020:A:Tdonor_gain1.0000
14:99851031:CAAAG:Cdonor_loss1.0000
14:99851032:AAAG:Adonor_loss1.0000
14:99851033:AAGG:Adonor_loss1.0000
14:99851036:GT:Gdonor_loss1.0000
14:99851037:T:Adonor_loss1.0000
14:99865508:TTACA:Tacceptor_loss1.0000
14:99865510:ACAG:Aacceptor_loss1.0000
14:99865511:CAG:Cacceptor_loss1.0000
14:99865512:A:AGacceptor_gain1.0000
14:99865513:G:Aacceptor_loss1.0000
14:99865513:G:GAacceptor_gain1.0000
14:99865513:GC:Gacceptor_gain1.0000
14:99865513:GCA:Gacceptor_gain1.0000
14:99865513:GCAA:Gacceptor_gain1.0000
14:99865642:AAAAG:Adonor_loss1.0000
14:99865644:AAGG:Adonor_loss1.0000
14:99865645:AGG:Adonor_loss1.0000
14:99865646:GGT:Gdonor_loss1.0000
14:99865647:G:GAdonor_loss1.0000
14:99865648:T:Adonor_loss1.0000

AlphaMissense

5338 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
14:99850949:T:CL55P1.000
14:99850961:T:CL59P1.000
14:99900953:T:AW308R1.000
14:99900953:T:CW308R1.000
14:99909412:G:AG391E1.000
14:99909432:T:AW398R1.000
14:99909432:T:CW398R1.000
14:99910332:T:AW444R1.000
14:99910332:T:CW444R1.000
14:99920790:T:AW608R1.000
14:99920790:T:CW608R1.000
14:99936050:G:AG644D1.000
14:99936256:A:CS673R1.000
14:99936257:G:TS673I1.000
14:99936258:C:AS673R1.000
14:99936258:C:GS673R1.000
14:99936259:T:CF674L1.000
14:99936261:C:AF674L1.000
14:99936261:C:GF674L1.000
14:99936277:T:AW680R1.000
14:99936277:T:CW680R1.000
14:99936304:T:CS689P1.000
14:99936310:T:CS691P1.000
14:99936311:C:TS691F1.000
14:99939281:A:CD759A1.000
14:99939281:A:TD759V1.000
14:99940024:T:AV787D1.000
14:99940098:T:AW812R1.000
14:99940098:T:CW812R1.000
14:99850907:T:CL41P0.999

dbSNP variants (sampled 300 via entrez): RS1000008963 (14:99813975 G>A), RS1000027117 (14:99809326 G>T), RS1000057326 (14:99740719 G>A), RS1000059448 (14:99822555 G>A,T), RS1000076282 (14:99767646 G>A), RS1000139251 (14:99800190 A>G), RS1000143595 (14:99864129 A>G,T), RS1000154140 (14:99908102 G>A), RS1000164980 (14:99768981 G>C,T), RS1000171760 (14:99860543 C>G,T), RS1000195676 (14:99744228 C>T), RS1000209788 (14:99738464 C>A), RS1000238200 (14:99887862 C>G), RS1000238933 (14:99910899 C>A,T), RS1000255581 (14:99799959 A>G)

Disease associations

OMIM: gene MIM:602033 | disease phenotypes: MIM:600348, MIM:617557

GenCC curated gene-disease

DiseaseClassificationInheritance
band heterotopia of brainStrongAutosomal recessive
subcortical band heterotopiaSupportiveAutosomal recessive

ClinGen Gene-Disease Validity (1)

Expert-panel classifications — Definitive > Strong > Moderate > Limited > Disputed > Refuted.

DiseaseClassificationInheritance
band heterotopia of brainDefinitiveAR

Mondo (3): band heterotopia of brain (MONDO:0010873), Gabriele de Vries syndrome (MONDO:0044738), subcortical band heterotopia (MONDO:0020491)

Orphanet (1): Gabriele-de Vries syndrome (Orphanet:506358)

HPO phenotypes

19 total (19 of 19 shown, HPO-id order):

HPOTerm
HP:0000007Autosomal recessive inheritance
HP:0000238Hydrocephalus
HP:0000256Macrocephaly
HP:0000708Atypical behavior
HP:0001250Seizure
HP:0001257Spasticity
HP:0001263Global developmental delay
HP:0001274Agenesis of corpus callosum
HP:0001357Plagiocephaly
HP:0002119Ventriculomegaly
HP:0002126Polymicrogyria
HP:0002282Gray matter heterotopia
HP:0002360Sleep disturbance
HP:0003577Congenital onset
HP:0006956Lateral ventricle dilatation
HP:0010864Severe intellectual disability
HP:0012736Profound global developmental delay
HP:0025517Hypoplastic hippocampus
HP:0032409Subcortical band heterotopia

GWAS associations

9 associations (top):

StudyTraitp-value
GCST003474_8Scalp hair shape1.000000e-07
GCST005194_177Coronary artery disease4.000000e-08
GCST006427_27Depression in smokers1.000000e-06
GCST007096_151Pulse pressure7.000000e-10
GCST007097_162Pulse pressure2.000000e-06
GCST007097_163Pulse pressure3.000000e-08
GCST008473_1Visceral fat3.000000e-06
GCST010703_106Brain morphology (MOSTest)1.000000e-20
GCST90000025_550Appendicular lean mass2.000000e-12

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0005763pulse pressure measurement
EFO:0004346neuroimaging measurement
EFO:0004980appendicular lean mass

MeSH disease descriptors (1)

DescriptorNameTree numbers
C563950Band Heterotopia of Brain (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

45 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, increases expression4
Air Pollutantsaffects cotreatment, decreases expression, increases abundance, increases expression3
sodium arsenitedecreases expression, increases expression2
methacrylaldehydedecreases expression, increases abundance, affects cotreatment2
Acroleinincreases abundance, affects cotreatment, decreases expression2
Ozoneaffects cotreatment, decreases expression, increases abundance2
Smokedecreases expression, increases abundance, increases expression2
Aflatoxin B1decreases expression2
aristolochic acid Idecreases expression1
FR900359increases phosphorylation1
2,4,6-tribromophenolincreases expression1
methylmercuric chlorideincreases expression1
alpha-pineneincreases abundance, affects cotreatment, decreases expression1
bisphenol Aaffects cotreatment, affects methylation, decreases methylation1
decabromobiphenyl etherdecreases expression1
arseniteaffects binding, decreases reaction1
cobaltous chloridedecreases expression1
potassium chromate(VI)decreases expression1
nickel sulfateincreases expression1
2-palmitoylglycerolincreases expression1
2,2’,4,4’-tetrabromodiphenyl etherincreases expression1
pentabrominated diphenyl ether 100increases expression1
hexabrominated diphenyl ether 153decreases expression1
jinfukangaffects cotreatment, decreases expression1
Temozolomideincreases expression1
Sunitinibdecreases expression1
Fulvestrantaffects cotreatment, affects methylation1
Acetaminophenincreases expression1
Benzo(a)pyreneaffects methylation1
Cadmiumincreases abundance, increases expression1

Cellosaurus cell lines

2 cell lines: 2 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_ZD03Mel 04.01Cancer cell lineMale
CVCL_ZD06Mel 12.07Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.